Abstract
Patients with obesity hypoventilation syndrome (OHS) have a lower quality of life, more healthcare expenses, a greater risk of pulmonary hypertension, and a higher mortality compared to eucapnic patients with obstructive sleep apnea (OSA). Despite significant morbidity and mortality associated with OHS, it is often unrecognized and treatment is frequently delayed. The objective of this observational study was to determine the prevalence of OHS in patients with OSA seen at the sleep disorders clinic of a large public urban hospital serving predominantly minority population and to identify clinical—not mechanistic—predictors that should prompt clinicians to measure arterial blood gases. In the first stage, we randomly selected 180 patients referred to our sleep disorders clinic between 2000 and 2004 for suspicion of OSA. From this retrospective random sample we calculated the prevalence of OHS in patients with OSA and identified independent clinical predictors using logistic regression. In the second stage, we prospectively validated these predictors in a sample of 410 consecutive patients referred to the sleep disorders clinic for suspicion of OSA between 2005 and 2006. The prevalence of OHS in patients with OSA was 30% in the retrospective random sample and 20% in the prospective sample. Three variables independently predicted OHS in both samples: serum bicarbonate level (p < 0.001), apnea–hypopnea index (p = 0.006), and lowest oxygen saturation during sleep (p < 0.001). Due to the serious morbidity associated with OHS, we selected a highly sensitive threshold of serum bicarbonate level. A threshold of 27 mEq/l had a sensitivity of 92% and a specificity of 50%. Only 3% of patients with a serum bicarbonate level <27 mEq/l had hypercapnia compared to 50% with a serum bicarbonate ≥27 mEq/l. In conclusion, OHS is common in severe OSA. A normal serum bicarbonate level excludes hypercapnia and an elevated serum bicarbonate level should prompt clinicians to measure arterial blood gases.
Similar content being viewed by others
References
Olson AL, Zwillich C (2005) The obesity hypoventilation syndrome. Am J Med 118:948–956
Anonymous (1999) Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. The report of an American Academy of Sleep Medicine Task Force. Sleep 22:667–689
Hida W (2003) Quality of life in obesity hypoventilation syndrome. Sleep Breath 7:1–2
Hida W, Okabe S, Tatsumi K, Kimura H, Akasiba T, Chin K, Ohi M, Nakayama H, Satoh M, Kuriyama T (2003) Nasal continuous positive airway pressure improves quality of life in obesity hypoventilation syndrome. Sleep Breath 7:3–12
Berg G, Delaive K, Manfreda J, Walld R, Kryger MH (2001) The use of health-care resources in obesity-hypoventilation syndrome. Chest 120:377–383
Kessler R, Chaouat A, Schinkewitch P, Faller M, Casel S, Krieger J, Weitzenblum E (2001) The obesity-hypoventilation syndrome revisited: a prospective study of 34 consecutive cases. Chest 120:369–376
Kessler R, Chaouat A, Weitzenblum E, Oswald M, Ehrhart M, Apprill M, Krieger J (1996) Pulmonary hypertension in the obstructive sleep apnoea syndrome: prevalence, causes and therapeutic consequences. Eur Respir J 9:787–794
Nowbar S, Burkart KM, Gonzales R, Fedorowicz A, Gozansky WS, Gaudio JC, Taylor MR, Zwillich CW (2004) Obesity-associated hypoventilation in hospitalized patients: prevalence, effects, and outcome. Am J Med 116:1–7
Carden KA, Fogel RB (2004) Obesity-associated hypoventilation—a “growing” concern. Am J Med 116:58–59
Resta O, Foschino Barbaro MP, Bonfitto P, Talamo S, Mastrosimone V, Stefano A, Giliberti T (2000) Hypercapnia in obstructive sleep apnoea syndrome. Neth J Med 56:215–222
Akashiba T, Kawahara S, Kosaka N, Ito D, Saito O, Majima T, Horie T (2002) Determinants of chronic hypercapnia in Japanese men with obstructive sleep apnea syndrome. Chest 121:415–421
Golpe R, Jimenez A, Carpizo R (2002) Diurnal hypercapnia in patients with obstructive sleep apnea syndrome. Chest 122:1100–1101 (author reply 1101)
Verin E, Tardif C, Pasquis P (2001) Prevalence of daytime hypercapnia or hypoxia in patients with OSAS and normal lung function. Respir Med 95:693–696
Laaban JP, Chailleux E (2005) Daytime hypercapnia in adult patients with obstructive sleep apnea syndrome in France, before initiating nocturnal nasal continuous positive airway pressure therapy. Chest 127:710–715
Mokdad AH, Ford ES, Bowman BA, Dietz WH, Vinicor F, Bales VS, Marks JS (2003) Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA 289:76–79
Leech JA, Onal E, Baer P, Lopata M (1987) Determinants of hypercapnia in occlusive sleep apnea syndrome. Chest 92:807–813
Anonymous (1995) Standardization of spirometry, 1994 update. American Thoracic Society. Am J Respir Crit Care Med 152:1107–1136
Anonymous (1992) EEG arousals: scoring rules and examples: a preliminary report from the Sleep Disorders Atlas Task Force of the American Sleep Disorders Association. Sleep 15:173–184
Moore L, Lavoie A, LeSage N, Liberman M, Sampalis JS, Bergeron E, Abdous B (2005) Multiple imputation of the Glasgow Coma Score. J Trauma 59:698–704
Rubin DB, Schenker N (1991) Multiple imputation in health–care databases: an overview and some applications. Stat Med 10:585–598
Schafer JL (1999) Multiple imputation: a primer. Stat Methods Med Res 8:3–15
Madias NE, Adrogue HJ, Horowitz GL, Cohen JJ, Schwartz WB (1979) A redefinition of normal acid–base equilibrium in man: carbon dioxide tension as a key determinant of normal plasma bicarbonate concentration. Kidney Int 16:612–618
Sakakibara H, Tong M, Matsushita K, Hirata M, Konishi Y, Suetsugu S (1999) Cephalometric abnormalities in non-obese and obese patients with obstructive sleep apnoea. Eur Respir J 13:403–410
Yu X, Fujimoto K, Urushibata K, Matsuzawa Y, Kubo K (2003) Cephalometric analysis in obese and nonobese patients with obstructive sleep apnea syndrome. Chest 124:212–218
Miech RA, Kumanyika SK, Stettler N, Link BG, Phelan JC, Chang VW (2006) Trends in the association of poverty with overweight among US adolescents, 1971–2004. JAMA 295:2385–2393
Javaheri S, Colangelo G, Lacey W, Gartside PS (1994) Chronic hypercapnia in obstructive sleep apnea–hypopnea syndrome. Sleep 17:416–423
Bradley TD, Rutherford R, Lue F, Moldofsky H, Grossman RF, Zamel N, Phillipson EA (1986) Role of diffuse airway obstruction in the hypercapnia of obstructive sleep apnea. Am Rev Respir Dis 134:920–924
Resta O, Foschino-Barbaro MP, Bonfitto P, Talamo S, Legari G, De Pergola G, Minenna A, Giorgino R (2000) Prevalence and mechanisms of diurnal hypercapnia in a sample of morbidly obese subjects with obstructive sleep apnoea. Respir Med 94:240–246
Ayappa I, Berger KI, Norman RG, Oppenheimer BW, Rapoport DM, Goldring RM (2002) Hypercapnia and ventilatory periodicity in obstructive sleep apnea syndrome. Am J Respir Crit Care Med 166:1112–1115
Adrogue HJ, Madias NE (1998) Arterial blood gas monitoring: acid base assessment. In: Tobin MJ (eds) Principles and practice of intensive care monitoring. McGraw-Hill, New York, pp 217–241
Madias NE, Wolf CJ, Cohen JJ (1985) Regulation of acid–base equilibrium in chronic hypercapnia. Kidney Int 27:538–543
Mokhlesi B, Tulaimat A, Evans AT, Wang Y, Itani A, Hassaballa HA, Herdegen JJ, Stepanski EJ (2006) Impact of adherence with positive airway pressure therapy on hypercapnia in obstructive sleep apnea. J Clin Sleep Med 2:57–62
Han F, Chen E, Wei H, He Q, Ding D, Strohl KP (2001) Treatment effects on carbon dioxide retention in patients with obstructive sleep apnea–hypopnea syndrome. Chest 119:1814–1819
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Mokhlesi, B., Tulaimat, A., Faibussowitsch, I. et al. Obesity hypoventilation syndrome: prevalence and predictors in patients with obstructive sleep apnea. Sleep Breath 11, 117–124 (2007). https://doi.org/10.1007/s11325-006-0092-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11325-006-0092-8